RetaMaps

IVitamin IV Lounge

IVitamin IV Lounge · 515 South Congress Avenue · Austin, TX 78704

4.9· 450 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

IVitamin IV Lounge is an IV therapy and wellness clinic in Austin, Texas, with weight-loss services listed alongside IV hydration. Its website says it was founded by licensed pharmacist Jana Gavin and wellness business strategist Jordan Cobb, operates two Austin lounges and offers mobile IV services, and it names Kasey Valencia, FNP-C. Telehealth is also listed. On Google it has a 4.9-star rating across 450 reviews dating to 2021, with 44 in the past year; reviewers mention the staff (45 reviews) and the team's knowledge most often.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 450 reviews
44
reviews in the past year (avg ★ 4.7)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-26. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 450 Google reviews. Of the 100 reviews we analyzed, 95 (95%) are positive (4–5★) and 4 (4%) are negative (1–2★).

What patients like

  • Friendly, helpful staff42 reviews
  • Knowledgeable, professional providers20 reviews
  • Clean, comfortable office9 reviews
  • Easy scheduling and communication5 reviews

Common complaints

  • Staff or front-desk issues2 of 4 negative
  • Felt rushed or unheard2 of 4 negative
5★
91
4★
4
3★
1
2★
2
1★
2

Most recent Google reviews

Betsy T.★★★★★2026-09-26

I am a hard person to stick with small veins and Gabe was kind and patient with me! I felt super great after the IV bag and definitely would come back!!! Amazing staff and service!

Debbie N.★★★★★2026-09-24

Everyone at the facility was great . This was my husbands first time there and my second. We’d been dehydrated and sluggish for some months now . We had numerous questions to see what IV drip best suited us. And Desiree who’s at the front desk was EXCEPTIONAL AND PATIENT with us. Not only did she answer all of our questions , she let us know of the great package available . We are going on our first resort trip next month and we are happy that this will only help us to feeling better before then . I will point out that my husband is Spanish speaking as his first language . With her limited Spanish she did her very best to make my husband as comfortable as possible . That really meant alot to me . The nurses that attended to us were very attentive and sweet as well. Lastly, the atmosphere there is just so relaxing and I love the massage chairs ❤️.

Jay B.★★★★★2026-09-20

This crew is awesome! Really accomodating and nice. Highly recommend.

Jordan W.★★★★★2026-09-19

This place is amazing such good service! Came in for a bachelor party and Malory took care of us!

Moe A.★★★★★2026-09-19

Great experience - staff very knowledgeable.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Austin

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs